Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RANI THERAPEUTICS HOLDINGS, INC.

(RANI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about RANI THERAPEUTICS HOLDINGS, INC.
01/07Rani Therapeutics Appoints Lisa Rometty to Board of Directors
AQ
01/05RANI THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
01/05Rani Therapeutics Holdings, Inc. Announces Appointment of Lisa Rometty as Director
CI
2021RANI THERAPEUTICS HOLDINGS, INC.(NAS : RANI) added to NASDAQ Biotechnology Index
CI
2021RANI THERAPEUTICS HOLDINGS, INC.(NAS : RANI) added to S&P Global BMI Index
CI
2021RANI THERAPEUTICS : Reports Third Quarter 2021 Financial Results, Provides Corporate Updat..
PU
2021RANI THERAPEUTICS HOLDINGS, INC. Management's Discussion and Analysis of Financial Con..
AQ
2021Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
2021Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
2021RANI THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Rani Therapeutics Appoints Lyn Baranowski to Board of Directors
AQ
2021Rani Therapeutics Holdings, Inc. Appoints Lyn Baranowski to Board of Directors
CI
2021Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthca..
AQ
2021RANI THERAPEUTICS HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
2021Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
GL
2021RANI THERAPEUTICS HOLDINGS, INC.(NAS : RANI) added to S&P TMI Index
CI
2021RANI THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
2021RANI THERAPEUTICS : Reports Second Quarter 2021 Financial Results, Provides Corporate Upda..
AQ
2021Rani Therapeutics Holdings, Inc. Announces Unaudited Consolidated Earnings Results for ..
CI
2021Rani Therapeutics Holdings, Inc. Appoints Talat Imran as Chief Executive Officer
CI
2021Rani Therapeutics Holdings, Inc. Announces Executive Appointments
CI
2021RANI THERAPEUTICS : Announces Appointment of Eric Groen as General Counsel
AQ
2021RANI THERAPEUTICS : Canaccord Genuity Starts Rani Therapeutics Holdings at Buy With $29 Pr..
MT
2021RANI THERAPEUTICS : BTIG Starts Rani Therapeutics Holdings at Buy With $24 Price Target
MT
2021RANI THERAPEUTICS : Cantor Fitzgerald Starts Rani Therapeutics Holdings at Overweight with..
MT
2021RANI THERAPEUTICS : Stifel Starts Rani Therapeutics Holdings at Buy with $24 Price Target
MT
2021RANI THERAPEUTICS : BofA Securities Starts Rani Therapeutics Holdings at Buy with $23 Pric..
MT
2021RANI THERAPEUTICS : Raises $84.3 Million in Gross Proceeds from IPO
MT
2021RANI THERAPEUTICS : Announces Closing of its Initial Public Offering and Full Exercise of ..
AQ
2021RANI THERAPEUTICS HOLDINGS, INC.(NAS : RANI) added to NASDAQ Composite Index
CI
2021RANI THERAPEUTICS : Prices $73.3 Million IPO At $11/Share
MT
2021Rani Therapeutics Announces Pricing of Initial Public Offering
GL
2021Rani Therapeutics Holdings, Inc. has completed an IPO in the amount of $73.333337 milli..
CI
2021Rani Therapeutics Holdings, Inc. has filed an IPO in the amount of $100 million.
CI